Pharma Journalist -

Lacerta Therapeutics, a leader in the development of adeno-associated virus (AAV) technologies for the treatment of central nervous system (CNS) diseases, announced a new AAV capsid…
Read More...

iECURE, a gene editing company focused on developing therapies that utilize mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with…
Read More...

Alcon and Aerie Pharmaceuticals announced the companies have entered into a definitive merger agreement through which Alcon will acquire Aerie. This transaction affirms Alcon’s…
Read More...

Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million,…
Read More...

Pfizer Inc. and BioNTech SE announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of…
Read More...

Gilead Sciences, Inc. announced that the European Commission (EC) has granted Marketing Authorization for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV…
Read More...

Ocelot Bio, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat complications of end-stage liver disease (ESLD), announced…
Read More...

On August 19, 2022, Porton Advanced Solutions (Porton Advanced) announced the completion of its Series B financing round with over US$80Million. Current round of financing was led by…
Read More...

SAE Media Group reports: James Drinkwater is chairing the 2nd Annual Aseptic Processing Conference, taking place on 19–20 September 2022, in London, UK. SAE Media Group proudly…
Read More...

Bristol Myers Squibb announced that it has successfully completed its acquisition of Turning Point Therapeutics, Inc. (“Turning Point”), in an all-cash transaction. With the completion…
Read More...